QQ客服 官方微博 反馈留言

	The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials
	Yan, Long; Xie, Feng; Lu, Jiongjiong; Ni, Qingqiang; Shi, Changying; Tang, Caixi; Yang, Jiamei*
刊名	BMC Gastroenterology
	2015
卷号	15期号:1页码:65
关键词	Ascites Cirrhosis Randomized controlled trials V2-receptor antagonist
ISSN号	1471-230X
DOI	10.1186/s12876-015-0297-z
URL标识	查看原文
WOS记录号	WOS:000356325000001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3321147
专题	中南大学
作者单位	1.[Yan, Long 2.Xie, Feng 3.Ni, Qingqiang 4.Lu, Jiongjiong 5.Shi, Changying 6.Yang, Jiamei] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment & Liver Transplantat, Shanghai 200438, Peoples R China.
推荐引用方式 GB/T 7714	Yan, Long,Xie, Feng,Lu, Jiongjiong,et al. The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials[J]. BMC Gastroenterology,2015,15(1):65.
APA	Yan, Long.,Xie, Feng.,Lu, Jiongjiong.,Ni, Qingqiang.,Shi, Changying.,...&Yang, Jiamei*.(2015).The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.BMC Gastroenterology,15(1),65.
MLA	Yan, Long,et al."The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials".BMC Gastroenterology 15.1(2015):65.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。